Review of the processes for FDA oversight of drugs, medical devices, and combination products.
作者信息
Sweet Burgunda V, Schwemm Ann K, Parsons Dawn M
机构信息
Drug Information Service, University of Michigan Health System, 1500 E. Medical Center Dr., Ann Arbor, MI 48109-5008, USA.
出版信息
J Manag Care Pharm. 2011 Jan-Feb;17(1):40-50. doi: 10.18553/jmcp.2011.17.1.40.
Abstract
摘要
相似文献
1
Review of the processes for FDA oversight of drugs, medical devices, and combination products.美国食品药品监督管理局对药品、医疗器械及组合产品监管流程综述。
J Manag Care Pharm. 2011 Jan-Feb;17(1):40-50. doi: 10.18553/jmcp.2011.17.1.40.
2
Pharmaceuticals and medical devices: FDA oversight. End-of-year issue brief.药品和医疗器械：美国食品药品监督管理局监管。年终问题简报。
Issue Brief Health Policy Track Serv. 2010 Jan 4:1-31.
3
Left to their own devices: breakdowns in United States medical device premarket review.放任自流：美国医疗器械上市前审查的崩溃。
PLoS Med. 2010 Jul 13;7(7):e1000280. doi: 10.1371/journal.pmed.1000280.
4
Off-label drug and device applications: meeting the challenge.药品和器械的非标签应用：应对挑战
Aesthet Surg J. 2010 May-Jun;30(3):485-6. doi: 10.1177/1090820X10374120.
5
6
Pharmaceuticals and medical devices: FDA oversight.药品和医疗器械：美国食品药品监督管理局的监管
Issue Brief Health Policy Track Serv. 2012 Jan 3:1-86.
7
8
Pharmaceuticals and Medical Devices: FDA Oversight.药品和医疗器械：美国食品药品监督管理局监管
Issue Brief Health Policy Track Serv. 2018 Dec 24;2018:1-42.
9
10
Devices, drugs, and the Food and Drug Administration: increasing implications for ischemic stroke.设备、药物与美国食品药品监督管理局：对缺血性中风的影响日益增加
Stroke. 2005 Feb;36(2):398-9. doi: 10.1161/01.STR.0000153057.07181.94. Epub 2005 Jan 6.
引用本文的文献
1
Cell-cell communication: new insights and clinical implications.细胞间通讯：新的见解和临床意义。
Signal Transduct Target Ther. 2024 Aug 7;9(1):196. doi: 10.1038/s41392-024-01888-z.
2
Progress in Wound-Healing Products Based on Natural Compounds, Stem Cells, and MicroRNA-Based Biopolymers in the European, USA, and Asian Markets: Opportunities, Barriers, and Regulatory Issues.欧洲、美国和亚洲市场基于天然化合物、干细胞和基于微小RNA的生物聚合物的伤口愈合产品进展：机遇、障碍与监管问题
Polymers (Basel). 2024 May 3;16(9):1280. doi: 10.3390/polym16091280.
3
Considerations for the development of a field-based medical device for the administration of adjunctive therapies for snakebite envenoming.用于蛇咬伤中毒辅助治疗给药的现场医疗设备开发的考量因素。
Toxicon X. 2023 Aug 19;20:100169. doi: 10.1016/j.toxcx.2023.100169. eCollection 2023 Dec.
4
Navigating regulatory pathways for translation of biologic cartilage repair products.生物软骨修复产品转化的监管途径探索。
Sci Transl Med. 2022 Aug 24;14(659):eabp8163. doi: 10.1126/scitranslmed.abp8163.
5
Recent Applications of Three Dimensional Printing in Cardiovascular Medicine.三维打印在心血管医学中的最新应用。
Cells. 2020 Mar 17;9(3):742. doi: 10.3390/cells9030742.
6
Challenges and potential solutions to the evaluation, monitoring, and regulation of surgical innovations.手术创新评估、监测与监管面临的挑战及潜在解决方案。
BMC Surg. 2019 Aug 27;19(1):119. doi: 10.1186/s12893-019-0586-5.
7
Drugs and Devices: Comparison of European and U.S. Approval Processes.药物与器械：欧洲和美国审批流程之比较
JACC Basic Transl Sci. 2016 Aug 29;1(5):399-412. doi: 10.1016/j.jacbts.2016.06.003. eCollection 2016 Aug.
8
The Economics and Regulation of PRP in the Evolving Field of Orthopedic Biologics.骨科生物制剂不断发展领域中富血小板血浆的经济学与监管
Curr Rev Musculoskelet Med. 2018 Dec;11(4):558-565. doi: 10.1007/s12178-018-9514-z.
9
Improving medical device regulation: the United States and Europe in perspective.改进医疗器械监管：美国和欧洲的视角。
Milbank Q. 2014 Mar;92(1):114-50. doi: 10.1111/1468-0009.12043.
10
Health Economics Information in Wound Care: The Elephant in the Room.伤口护理中的卫生经济学信息：房间里的大象（指被忽视的重要问题）
Adv Wound Care (New Rochelle). 2013 Dec;2(10):563-570. doi: 10.1089/wound.2013.0479.
Zotero 插件